Commercial real estate deal volume drops for first time in nearly 2 years


A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox.

The recovery in commercial real estate has been slow and bumpy, much like interest rate policy over the past few years. The two, of course, are deeply connected.

After gaining significant momentum coming out of the pandemic, this year has been rough. October was the first month of negative year-over-year transaction volume growth since the post-Fed rate hike recovery began in early 2024, according to monthly data provided by Moody’s as a media exclusive to CNBC’s Property Play. It tracks the top 50 commercial real estate, or CRE, property sales across the U.S.

Deal volume growth turned positive in the early part of last year and was even approaching pre-Covid levels by year-end.

“More than an imminent downturn in the CRE capital markets, the slip to negative growth in October 2025 reflects the stalemate going on between buyers and sellers,” said Kevin Fagan, head of CRE capital market research at Moody’s. “The bottom of the U-shaped recovery from 2023 low volumes has been lengthened by persistently high interest rates and policy and economic uncertainty of 2025.”

But October was still an active month. There were $24.4 billion of sales, which is roughly 70% of October 2019 sales. Total dollar volume is still higher this year than it was last year, but the momentum of growth has slowed significantly since 2023.

Looking at specific property trends, industrial and multifamily led the top 50 deals. The only sector to improve in deal volume compared with last year was hotel. It saw 6% growth after a negative third quarter.

One notable sale: The New York Edition hotel at 5 Madison Avenue was sold for $231.2 million by the Abu Dhabi Investment Authority, a sovereign wealth fund, to the Kam Sang Company, a real estate development firm.

“The New York Edition hotel is an interesting one because of both the sales price being so high, a Mideast sovereign wealth fund pulling out of NYC, and the history of the building,” said Fagan, noting that it was originally an office building called the MetLife Clock Tower and was the tallest building in the world for roughly three years from 1910 to 1913.

Met Life clock tower and pedestrian bridge, Madison Avenue, New York.

Education Images | Universal Images Group | Getty Images

Both the Clock Tower and the Woolworth building, which was also once the tallest in the world, were converted to hotel and residential, respectively, starting around 2013.

“They are nearly worthless as offices, but extremely valuable as a hotel and an apartment building, respectively,” Fagan added.

Meanwhile the multifamily segment saw the biggest pullback in October, down 27% from 2024. It had been showing volumes that were higher than pre-Covid levels in the four months before, and, despite the pullback, buildings were mostly trading at a premium to previous sales.

Get Property Play directly to your inbox

CNBC’s Property Play with Diana Olick covers new and evolving opportunities for the real estate investor, delivered weekly to your inbox.

Subscribe here to get access today.

Office continued its rocky recovery, with either discounts or property conversions as part of the story.

The top October sale was of the Sotheby’s headquarters to Weill Cornell, which probably means a repurposing to health care or medical office, according to Fagan.

New York Life picked up a distressed Manhattan office building from BGO for almost half of its last sale price in 2015.

“It shows there is institutional interest in offices sold at discounts, reinforcing the long-term value floor for office buildings in good markets, and the recognized enduring utility of such properties,” Fagan said.


Related Posts

Eli Lilly (LLY) earnings Q4 2025

Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly on Wednesday posted fourth-quarter earnings and…

Pfizer (PFE) earnings Q4 2025

Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its modest 2026 guidance that rattled investors in December. The pharmaceutical…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aaron George provides the calm to steer India past Afghanistan’s mammoth total in U19 World Cup semi-final

  • By admin
  • February 4, 2026
  • 0 views
Aaron George provides the calm to steer India past Afghanistan’s mammoth total in U19 World Cup semi-final

US stock futures point to flat start for Wall Street after Anthropic AI-led tech selloff

  • By admin
  • February 4, 2026
  • 1 views
US stock futures point to flat start for Wall Street after Anthropic AI-led tech selloff

Eli Lilly (LLY) earnings Q4 2025

  • By admin
  • February 4, 2026
  • 2 views
Eli Lilly (LLY) earnings Q4 2025

NFLPA head says players have ‘no appetite’ for 18-game season

  • By admin
  • February 4, 2026
  • 0 views
NFLPA head says players have ‘no appetite’ for 18-game season

IND vs SA Live Score: India face South Africa in T20 World Cup warm-up

  • By admin
  • February 4, 2026
  • 1 views
IND vs SA Live Score: India face South Africa in T20 World Cup warm-up

Will HHS Enhance or Stall the Promise of Artificial Intelligence for Healthcare? – The Health Care Blog

  • By admin
  • February 4, 2026
  • 2 views
Will HHS Enhance or Stall the Promise of Artificial Intelligence for Healthcare? – The Health Care Blog